These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 4970415

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
    Korotaev GA, Kozulitsyna TI, Tret'iakova EA, Mamed'iarova FA.
    Probl Tuberk; 1986; (7):32-6. PubMed ID: 3094001
    [No Abstract] [Full Text] [Related]

  • 4. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V, Muzikravić T.
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract] [Full Text] [Related]

  • 5. [Changes and patterns of drug resistance of mycobacterium tuberculosis in patients with pulmonary tuberculosis (by data of the microbiological laboratory of research production association "Phthysiology")].
    Gorokhova TV.
    Probl Tuberk; 1997; (2):33-5. PubMed ID: 9235582
    [Abstract] [Full Text] [Related]

  • 6. [2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin].
    Krasucka-Kluźniak A, Krakówka P.
    Pneumonol Pol; 1989 Apr; 57(4):249-52. PubMed ID: 2516906
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effectiveness of ethambutol in chronic pulmonary tuberculosis].
    Golli V, Stefanin E, Chiper P, Stefănescu I, Popescu-Crivina IM, Anghel E, Kosinski E, Daha A, Kosinski M, Floricel N.
    Ftiziologia; 1972 Apr; 21(5):489-94. PubMed ID: 4632131
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Experience in treating tuberculosis patients in the IB outpatient registry group].
    Smirnov GA, Valitova ZIu, Fattakhova RM, Anastas'ev VS.
    Probl Tuberk; 1986 Apr; (4):12-5. PubMed ID: 3086863
    [No Abstract] [Full Text] [Related]

  • 11. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
    Telejko Z.
    Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical aspects of secondary resistance in pulmonary tuberculosis].
    Gugić B.
    Plucne Bolesti; 1985 Oct; 37(1-2):22-7. PubMed ID: 3934690
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Ethambutol in the treatment of chronic pulmonary tuberculosis with bacilli resistant to tuberculostatics].
    Anastasatu C, Kaufman S, Barcan F, Gheorghiu M, Cristea M, Ulpian C, Iancovici O.
    Ftiziologia; 1971 Oct; 20(4):373-9. PubMed ID: 5005706
    [No Abstract] [Full Text] [Related]

  • 16. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG, Chukanov VI, Korneev AA.
    Probl Tuberk; 1996 Oct; (6):42-4. PubMed ID: 9019768
    [Abstract] [Full Text] [Related]

  • 17. [Effect of aggravating factors on the effectiveness of the treatment of newly detected patients with destructive pulmonary tuberculosis].
    Zozuliak VI.
    Vrach Delo; 1988 Jun; (6):54-5. PubMed ID: 3138824
    [No Abstract] [Full Text] [Related]

  • 18. [Epidemiological and clinical significance of resistant tuberculosis bacteria].
    Sighart H.
    Wien Med Wochenschr; 1968 Oct 26; 118(43):923-5. PubMed ID: 4973923
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.